Search results

Page results

• UCLH recruits first participant in Europe to remdesivir outpatient study

  UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.

• WEB Intracranial aneurysm device in the treatment of cerebral aneurysms

  This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms

• Outpatients clinics during COVID-19

  Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.

• Infectious disease update during COVID-19

  All GPs are now welcome to use our national Infectious & Tropical Disease Advice and Guidance function on the e-referral system (NHS e-RS)

• Study sheds light on accidental awareness during pregnancy-related surgery and how to prevent it

  Around 1 in 250 women may experience consciousness during pregnancy-related surgery under general anaesthesia, according to a national study which sheds light on why this occurs.

• Preterm babies do not habituate to repeated pain

  Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, finds a study at UCLH and UCL.

• Well done #teamUCLH on a fantastic London Landmarks Half Marathon

  Well done to everyone who ran to support UCLH in the iconic London Landmarks Half Marathon on 2 April!

• ‘Virtual wards’ help patients to recover at home

  The UCLH@Home service is helping patients like 80-year-old Margaret Stone to continue their recovery in their own home under the care of their hospital team.

• Research seeking greater understanding of rare blood cancer and how to treat it

  A new research study at UCLH and UCL will investigate how a rare type of blood cancer develops and what types of treatment may be effective for patients.

• UCLH doses first patient in the world in Covid-19 antibody trial

  UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.